Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Comparison of Long-Acting G-Csf (Pd-Lasta) With Short-Acting G-Csf (Pd-Grastim) in Neutrophil Recovery Following Consolidation Chemotherapy With High-Dose Cytarabine in Acute Myeloid Leukemia: A Randomized Clinical Trial Publisher



Esfandbod M1 ; Bararzadeh FA1 ; Faraz M1 ; Zarrabi F1 ; Toogeh G1
Authors

Source: International Journal of Hematology-Oncology and Stem Cell Research Published:2021


Abstract

Background: Acute myeloid leukemia (AML) patients are often neutropenic as a result of their disease alone or following their chemotherapy. In this randomized clinical trial the efficacy of Iranian short-acting (PD-Grastim) and long-acting G-CSF (PD-Lasta) were compared in term of time to recovery from neutropenia in de novo AML patients following the consolidation chemotherapy. Materials and Methods: Patients (n = 51) received one or two courses of Cytarabine and Daunorubicin as an induction. If complete remission was achieved, the treatment was followed by high-dose Cytarabine as consolidation chemotherapy. Twenty four hours after the consolidation chemotherapy, patient were randomized to receive either daily short-acting G-CSF (PD-Grastim) (300 µg/kg) or single-dose long-acting G-CSF (PD-Lasta) (6 mg). Results: The median time to recovery of neutrophils was 11.00 and 13.00 days for short-acting G-CSF (PD-Grastim) (n=22) and long-acting G-CSF (PD-Lasta) (n=29) groups, respectively (U=186.5, P>0.05 two-tailed). Incidence of adverse effects was similar in both short-acting G-CSF (PD-Grastim) and long-acting G-CSF (PD-Lasta) groups. Conclusion: Overall, data show that Iranian long-acting G-CSF (PD-Lasta) was not significantly different with Iranian short-acting G-CSF (PD-Grastim). © 2021 Tehran University of Medical Sciences.
Other Related Docs
5. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
9. High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome, International Journal of Hematology-Oncology and Stem Cell Research (2017)
14. Successful Outcome of Autologous Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors, International Journal of Hematology-Oncology and Stem Cell Research (2018)
20. Immunotherapy in Aml: A Brief Review on Emerging Strategies, Clinical and Translational Oncology (2021)